Literature DB >> 16306598

Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Ijad Madisch1, Gabi Harste, Heidi Pommer, Albert Heim.   

Abstract

Human adenoviruses (HAdV) are responsible for a wide spectrum of diseases. The neutralization epsilon determinant (loops 1 and 2) and the hemagglutination gamma determinant are relevant for the taxonomy of HAdV. Precise type identification of HAdV prototypes is crucial for detection of infection chains and epidemiology. epsilon and gamma determinant sequences of all 51 HAdV were generated to propose molecular classification criteria. Phylogenetic analysis of epsilon determinant sequences demonstrated sufficient genetic divergence for molecular classification, with the exception of HAdV-15 and HAdV-29, which also cannot be differentiated by classical cross-neutralization. Precise sequence divergence criteria for typing (<2.5% from loop 2 prototype sequence and <2.4% from loop 1 sequence) were deduced from phylogenetic analysis. These criteria may also facilitate identification of new HAdV prototypes. Fiber knob (gamma determinant) phylogeny indicated a two-step model of species evolution and multiple intraspecies recombination events in the origin of HAdV prototypes. HAdV-29 was identified as a recombination variant of HAdV-15 (epsilon determinant) and a speculative, not-yet-isolated HAdV prototype (gamma determinant). Subanalysis of molecular evolution in hypervariable regions 1 to 6 of the epsilon determinant indicated different selective pressures in subclusters of species HAdV-D. Additionally, gamma determinant phylogenetic analysis demonstrated that HAdV-8 did not cluster with -19 and -37 in spite of their having the same tissue tropism. The phylogeny of HAdV-E4 suggested origination by interspecies recombination between HAdV-B (hexon) and HAdV-C (fiber), as in simian adenovirus 25, indicating additional zoonotic transfer. In conclusion, molecular classification by systematic sequence analysis of immunogenic determinants yields new insights into HAdV phylogeny and evolution.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306598      PMCID: PMC1316018          DOI: 10.1128/JVI.79.24.15265-15276.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved.

Authors:  V Venard; A Carret; D Corsaro; P Bordigoni; A Le Faou
Journal:  J Hosp Infect       Date:  2000-01       Impact factor: 3.926

2.  Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease.

Authors:  L K Crawford-Miksza; R N Nang; D P Schnurr
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

3.  Multiplex polymerase chain reaction for subgenus-specific detection of human adenoviruses in clinical samples.

Authors:  P Pring-Akerblom; F E Trijssenaar; T Adrian; H Hoyer
Journal:  J Med Virol       Date:  1999-05       Impact factor: 2.327

4.  Typing of human enteroviruses by partial sequencing of VP1.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M R Flemister; B A Brown; M A Pallansch
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Further observation on typing adenoviruses and a description of two possible additional serotypes.

Authors:  L ROSEN; J F HOVIS; J A BELL
Journal:  Proc Soc Exp Biol Med       Date:  1962 Aug-Sep

6.  Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis.

Authors:  A Dakhama; R G Hegele; G Laflamme; E Israël-Assayag; Y Cormier
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

7.  Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively.

Authors:  J C De Jong; A G Wermenbol; M W Verweij-Uijterwaal; K W Slaterus; P Wertheim-Van Dillen; G J Van Doornum; S H Khoo; J C Hierholzer
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature.

Authors:  Kathrin Seidemann; Albert Heim; Eva D Pfister; Harald Köditz; Andreas Beilken; Annette Sander; Michael Melter; Karl-Walter Sykora; Michael Sasse; Armin Wessel
Journal:  Am J Transplant       Date:  2004-12       Impact factor: 8.086

9.  PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease.

Authors:  M S Echavarria; S C Ray; R Ambinder; J S Dumler; P Charache
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  61 in total

1.  The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity.

Authors:  Chi Ying Cheng; Timra Gilson; Frédéric Dallaire; Gary Ketner; Philip E Branton; Paola Blanchette
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  Overreliance on the hexon gene, leading to misclassification of human adenoviruses.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Timothy Schmidt; Donald Seto; Morris S Jones; David W Dyer; James Chodosh
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 3.  Genomic foundations of evolution and ocular pathogenesis in human adenovirus species D.

Authors:  Ashrafali Mohamed Ismail; Xiaohong Zhou; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  FEBS Lett       Date:  2019-12-11       Impact factor: 4.124

4.  Extent of circulation of incorrectly labeled adenovirus 50 and 51 prototype preparations.

Authors:  Ijad Madisch; Albert Heim
Journal:  J Clin Microbiol       Date:  2007-06       Impact factor: 5.948

5.  Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design.

Authors:  Ijad Madisch; Soeren Hofmayer; Christian Moritz; Alexander Grintzalis; Jens Hainmueller; Patricia Pring-Akerblom; Albert Heim
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

6.  Human adenovirus type 52: a type 41 in disguise?

Authors:  J C de Jong; A D M E Osterhaus; Morris S Jones; Balázs Harrach
Journal:  J Virol       Date:  2008-04       Impact factor: 5.103

7.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

8.  Simian adenovirus type 35 has a recombinant genome comprising human and simian adenovirus sequences, which predicts its potential emergence as a human respiratory pathogen.

Authors:  Shoaleh Dehghan; Jason Seto; Morris S Jones; David W Dyer; James Chodosh; Donald Seto
Journal:  Virology       Date:  2013-10-08       Impact factor: 3.616

9.  Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen.

Authors:  Michael P Walsh; Jason Seto; Morris S Jones; James Chodosh; Wenbo Xu; Donald Seto
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

10.  Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis.

Authors:  Hiroaki Ishiko; Yasushi Shimada; Tsunetada Konno; Akio Hayashi; Takeshi Ohguchi; Yoshitsugu Tagawa; Koki Aoki; Shigeaki Ohno; Shudo Yamazaki
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.